Jeanette E. Eckel‐Passow

11.1k total citations
119 papers, 3.7k citations indexed

About

Jeanette E. Eckel‐Passow is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Jeanette E. Eckel‐Passow has authored 119 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 35 papers in Pulmonary and Respiratory Medicine and 26 papers in Genetics. Recurrent topics in Jeanette E. Eckel‐Passow's work include Renal cell carcinoma treatment (25 papers), Glioma Diagnosis and Treatment (20 papers) and Renal and related cancers (18 papers). Jeanette E. Eckel‐Passow is often cited by papers focused on Renal cell carcinoma treatment (25 papers), Glioma Diagnosis and Treatment (20 papers) and Renal and related cancers (18 papers). Jeanette E. Eckel‐Passow collaborates with scholars based in United States, China and Belarus. Jeanette E. Eckel‐Passow's co-authors include Larry M. Baddour, Majdi N. Al‐Hasan, Brian D. Lahr, Daniel Serie, Alexander S. Parker, Terry M. Therneau, Robert B. Jenkins, John C. Cheville, Richard W. Joseph and Ann L. Oberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Jeanette E. Eckel‐Passow

113 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeanette E. Eckel‐Passow United States	36	1.6k	732	638	628	523	119	3.7k
Avi Z. Rosenberg United States	37	2.4k 1.4×	414 0.6×	505 0.8×	571 0.9×	761 1.5×	163	5.8k
Rita Mancini Italy	36	2.1k 1.3×	627 0.9×	950 1.5×	956 1.5×	368 0.7×	199	4.3k
Tatsuaki Tsuruyama Japan	29	988 0.6×	639 0.9×	266 0.4×	715 1.1×	257 0.5×	147	3.2k
Felix Lasitschka Germany	40	1.5k 0.9×	597 0.8×	550 0.9×	874 1.4×	632 1.2×	122	4.6k
Michael S. Wade United States	29	1.2k 0.7×	918 1.3×	187 0.3×	393 0.6×	471 0.9×	62	3.2k
Javier Corral Spain	37	1.4k 0.9×	558 0.8×	507 0.8×	328 0.5×	294 0.6×	235	5.2k
Yan Li China	31	1.5k 0.9×	1.0k 1.4×	770 1.2×	1.5k 2.5×	407 0.8×	207	4.4k
Sen‐Yung Hsieh Taiwan	33	1.7k 1.0×	330 0.5×	563 0.9×	444 0.7×	1.2k 2.3×	96	4.2k
Maria M. Picken United States	46	2.6k 1.6×	1.6k 2.2×	403 0.6×	1.0k 1.6×	372 0.7×	178	6.1k
Michele Battaglia Italy	48	2.0k 1.2×	2.4k 3.3×	1.1k 1.8×	734 1.2×	547 1.0×	219	6.1k

Countries citing papers authored by Jeanette E. Eckel‐Passow

Since Specialization

Citations

This map shows the geographic impact of Jeanette E. Eckel‐Passow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanette E. Eckel‐Passow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanette E. Eckel‐Passow more than expected).

Fields of papers citing papers by Jeanette E. Eckel‐Passow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanette E. Eckel‐Passow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanette E. Eckel‐Passow. The network helps show where Jeanette E. Eckel‐Passow may publish in the future.

Co-authorship network of co-authors of Jeanette E. Eckel‐Passow

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanette E. Eckel‐Passow. A scholar is included among the top collaborators of Jeanette E. Eckel‐Passow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanette E. Eckel‐Passow. Jeanette E. Eckel‐Passow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laverty, Daniel J., Surabhi Talele, Brett L. Carlson, et al.. (2024). Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization. Science Translational Medicine. 16(734). eadj5962–eadj5962. 14 indexed citations

Wendt, George A., Lucie McCoy, Helen M. Hansen, et al.. (2024). Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide. Neuro-Oncology. 27(5). 1385–1398.

Ostrom, Quinn T., Tian Ge, Beatrice Melin, et al.. (2024). Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes. Neuro-Oncology. 26(10). 1933–1944. 5 indexed citations

Rathi, Sneha, Michael P. Grams, Rachael A. Vaubel, et al.. (2024). Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628. Molecular Cancer Therapeutics. 24(2). 299–309.

Jain, Sonia, Jessica I. Griffith, Sneha Rathi, et al.. (2024). Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models. Clinical Cancer Research. 30(15). 3287–3297. 9 indexed citations

Conte, Gian Marco, Mana Moassefi, Shahriar Faghani, et al.. (2023). NIMG-57. PERFORMANCE OF DEEP LEARNING IN MGMT PROMOTER METHYLATION STATUS PREDICTION USING BRAIN MRI: RESULTS FROM A LARGE COHORT OF IDH-WILDTYPE GLIOMAS TESTED BY A SINGLE METHYLATION ASSAY. Neuro-Oncology. 25(Supplement_5). v199–v199. 1 indexed citations

Lacey, Jean M., Lucas P. Carlstrom, Arthur E. Warrington, et al.. (2023). Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas. Neuro-Oncology Advances. 5(1). vdad061–vdad061. 9 indexed citations

Eckel‐Passow, Jeanette E., Daniel H. Lachance, Paul A. Decker, et al.. (2022). Inherited genetics of adult diffuse glioma and polygenic risk scores—a review. Neuro-Oncology Practice. 9(4). 259–270. 3 indexed citations

Campos, Alejandro, Lizeth Cifuentes, Anas Hashem, et al.. (2022). Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case–Control Study. Obesity Surgery. 32(8). 2632–2640. 26 indexed citations

10.

Kachuri, Linda, George A. Wendt, Helen M. Hansen, et al.. (2022). The immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survival. The American Journal of Human Genetics. 109(6). 1105–1116. 9 indexed citations

11.

Conte, Gian Marco, Alexander D. Weston, Kenneth A. Philbrick, et al.. (2021). Generative Adversarial Networks to Synthesize Missing T1 and FLAIR MRI Sequences for Use in a Multisequence Brain Tumor Segmentation Model. Radiology. 299(2). 313–323. 76 indexed citations

12.

Cifuentes, Lizeth, Maria D. Hurtado, Jeanette E. Eckel‐Passow, & Andrés Acosta. (2021). Precision Medicine for Obesity. PubMed. 5(3). 239–248. 19 indexed citations

13.

Campos, Alejandro, Gerardo Calderón, Lizeth Cifuentes, et al.. (2021). Association of gastric emptying with postprandial appetite and satiety sensations in obesity. Obesity. 29(9). 1497–1507. 23 indexed citations

14.

Ye, Zhenqing, Haidong Dong, Tao Ma, et al.. (2018). Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance. Clinical Cancer Research. 24(14). 3299–3308. 40 indexed citations

15.

Hart, Steven N., Marissa S. Ellingson, Peter T. Vedell, et al.. (2016). Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer. BMJ Open. 6(4). e010332–e010332. 28 indexed citations

16.

Pokorny, Jenny L., David Calligaris, Shiv K. Gupta, et al.. (2015). The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma. Clinical Cancer Research. 21(8). 1916–1924. 71 indexed citations

17.

Walsh, Kyle M., Adam J. de Smith, Helen M. Hansen, et al.. (2015). A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer Research. 75(22). 4884–4894. 31 indexed citations

18.

Perez, Edith A., E. Aubrey Thompson, Karla V. Ballman, et al.. (2015). Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial. Journal of Clinical Oncology. 33(7). 701–708. 144 indexed citations

19.

Reinholz, Monica M., Jeanette E. Eckel‐Passow, S. Keith Anderson, et al.. (2010). Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL®platform. BMC Medical Genomics. 3(1). 60–60. 11 indexed citations

20.

Knoll, Bettina M., et al.. (2009). Temporal Trends in the Incidence ofStaphylococcus aureusBacteremia in Olmsted County, Minnesota, 1998 to 2005: A Population‐Based Study. Clinical Infectious Diseases. 49(12). e130–e138. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact